Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Erasca, Inc. (ERAS) Market Cap & Valuation Ratios

Erasca, Inc. (ERAS) has a market cap of $5.0B, with earnings according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ERASErasca, Inc.Follow ERAS — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
5.0B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days

Peers

biotechnology · nearest by market cap · trailing 12 months
CompanyMkt cap, $BP/EEV/SalesEV/EBITDAFCF yieldRev. growthOp. marginROIC
ERAS5.0———-1.9%——-97%
CGON5.5—713.7—-3.3%+1030%—-25%
COGT5.4—615.8—-5.7%——-120%
ORKA5.3———-1.9%——-28%
MIRM5.2—8.9—-4.4%+44%-135%-224%
PTCT5.1—3.418.9-0.8%-43%12%—
SRRK5.1———-5.9%——-568%
DFTX4.8———-3.5%——-92%
CRSP4.8—223.8—-7.8%-65%—-30%
TVTX4.7—8.5219.52.0%+77%-7%-8%
GOSS4.6—86.3—-3.5%+32%-312%—
Median of these 10—86.3119.2-3.5%+38%-71%-61%

.

Growth vs. price

each dot a company · hover or tap for values

Erasca, Inc. — questions

What is Erasca, Inc.'s market cap?
$5.0B.

Every figure on this page comes from Erasca, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.